Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres

Background: Filgotinib, an oral Janus kinase 1 preferential inhibitor, has been shown to be an effective treatment for ulcerative colitis (UC) in pre-registration studies. We aimed to describe the treatment population, effectiveness and safety of filgotinib in a real-world cohort of patients with UC...

Full description

Saved in:
Bibliographic Details
Main Authors: David Young, Sohail Rahmany, Deborah Taylor, Emma Davis, Michael Colwill, Sonia Kalyanji Mehta, Roisin Campbell, Karl Hazel, Karishma Sethi-Arora, Susan Ritchie, Ashley I Heinson, Helen Moyses, Keith Bodger, Emma Johnston, Lucy Hicks, Anjan Dhar, Jimmy Limdi, Rachel Cooney, John Paul Seenan, Kamal Patel, Alissa Walsh, Fraser Cummings
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2025-01-01
Series:Drugs in Context
Subjects:
colitis
filgotinib
quality of life
ulcerative colitis
Online Access:https://www.drugsincontext.com/real-world-assessment-of-effectiveness-and-safety-of-filgotinib-in-286-patients-with-ulcerative-colitis-in-9-uk-centres/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.drugsincontext.com/real-world-assessment-of-effectiveness-and-safety-of-filgotinib-in-286-patients-with-ulcerative-colitis-in-9-uk-centres/

Similar Items